The Procter & Gamble Company
The Procter & Gamble Company (PRG.DE) Financial Performance & Income Statement Overview
Explore the financials of The Procter & Gamble Company (PRG.DE), including yearly and quarterly data on income, cash flow, and balance sheets.
The Procter & Gamble Company (PRG.DE) Income Statement & Financial Overview
Explore comprehensive income reports for The Procter & Gamble Company PRG.DE, broken down by year and quarter.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $19.78B | $21.88B | $21.74B | $20.53B |
| Cost of Revenue | $9.69B | $10.42B | $10.42B | $10.35B |
| Gross Profit | $10.08B | $11.46B | $11.32B | $10.18B |
| Gross Profit Ratio | $0.51 | $0.52 | $0.52 | $0.50 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $5.52B | $5.72B | $5.52B | $6.30B |
| Operating Expenses | $5.52B | $5.72B | $5.52B | $6.30B |
| Total Costs & Expenses | $15.22B | $16.14B | $15.94B | $16.65B |
| Interest Income | $111.00M | $119.00M | $135.00M | $107.00M |
| Interest Expense | $217.00M | $240.00M | $238.00M | $220.00M |
| Depreciation & Amortization | $690.00M | $706.00M | $728.00M | $761.00M |
| EBITDA | $5.57B | $6.79B | $6.11B | $4.85B |
| EBITDA Ratio | $0.28 | $0.31 | $0.28 | $0.24 |
| Operating Income | $4.56B | $5.74B | $5.80B | $3.88B |
| Operating Income Ratio | $0.23 | $0.26 | $0.27 | $0.19 |
| Other Income/Expenses (Net) | $103.00M | $104.00M | -$657.00M | -$15.00M |
| Income Before Tax | $4.66B | $5.84B | $5.14B | $3.87B |
| Income Before Tax Ratio | $0.24 | $0.27 | $0.24 | $0.19 |
| Income Tax Expense | $868.00M | $1.19B | $1.15B | $726.00M |
| Net Income | $3.77B | $4.63B | $3.96B | $3.14B |
| Net Income Ratio | $0.19 | $0.21 | $0.18 | $0.15 |
| EPS | $1.58 | $1.94 | $1.65 | $1.30 |
| Diluted EPS | $1.54 | $1.88 | $1.58 | $1.27 |
| Weighted Avg Shares Outstanding | $2.35B | $2.35B | $2.36B | $2.47B |
| Weighted Avg Shares Outstanding (Diluted) | $2.45B | $2.46B | $2.47B | $2.47B |
Over the last four quarters, The Procter & Gamble Company's revenue moved from $20.53B in Q4 2024 to $19.78B in Q3 2025. Operating income in Q3 2025 was $4.56B, with a strong operating margin of 23%. Despite fluctuations in R&D and SG&A expenses, EBITDA for The Procter & Gamble Company remained robust at $5.57B, reflecting operational efficiency. Net income dropped to $3.77B, with an EPS of $1.58. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan